نتایج جستجو برای: anthracyclines

تعداد نتایج: 3200  

Journal: :Blood 2011
Harald Ehrhardt David Schrembs Christian Moritz Franziska Wachter Subrata Haldar Ulrike Graubner Michaela Nathrath Irmela Jeremias

Application of anthracyclines and Vinca alkaloids on the same day represents a hallmark of polychemotherapy protocols for hematopoietic malignancies. Here we show, for the first time, that both drugs might act most efficiently if they are applied on different days. Proof-of-concept studies in 18 cell lines revealed that anthracyclines inhibited cell death by Vinca alkaloids in 83% of cell lines...

2017
Junbin Wang Rongsheng Zheng Zishu Wang Yan Yang Mingxi Wang Weiyan Zou

BACKGROUND This study aimed to compare the efficacy and safety of vinorelbine plus cisplatin (NP regimen) vs. gemcitabine plus cisplatin (GP regimen) for treatment of metastatic TNBC after failure with anthracyclines and taxanes. MATERIAL AND METHODS A total of 48 patients with metastatic TNBC that failed in anthracyclines and taxanes treatment were enrolled and randomly grouped. Patients in th...

2017
Synnøve Yndestad Eilin Austreid Ida R. Svanberg Stian Knappskog Per E. Lønning Hans P. Eikesdal

Anthracyclines are key components of human breast cancer chemotherapy. Here, we explored the role of Akt signaling in anthracycline resistance.The antitumor activity of doxorubicin and Akt inhibitor A-443654 alone or combined was examined in estrogen receptor (ER) positive and negative human breast cancer cell lines. Further, we examined mRNA changes induced by anthracyclines in locally advance...

2017
Ying Pang Chunzhang Yang Jan Schovanek Herui Wang Petra Bullova Veronika Caisova Garima Gupta Katherine I. Wolf Gregg L. Semenza Zhengping Zhuang Karel Pacak

Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are rare, neuroendocrine tumors derived from adrenal or extra-adrenal chromaffin cells, respectively. Metastases are discovered in 3-36% of patients at the time of diagnosis. Currently, only suboptimal treatment options exist. Therefore, new therapeutic compounds targeting metastatic PHEOs/PGLs are urgently needed. Here, we investigated if ant...

Journal: :Cardiovascular & hematological agents in medicinal chemistry 2010
Lucia Prezioso Silvia Tanzi Federica Galaverna Caterina Frati Beatrice Testa Monia Savi Gallia Graiani Costanza Lagrasta Stefano Cavalli Serena Galati Denise Madeddu Elisa Lodi Rizzini Francesca Ferraro Ezio Musso Donatella Stilli Konrad Urbanek Elena Piegari Antonella De Angelis Attilio Maseri Francesco Rossi Eugenio Quaini Federico Quaini

Cardiovascular diseases and cancer represent respectively the first and second cause of death in industrialized countries. These two conditions may become synergistic when cardiovascular complications of anti-cancer therapy are considered. More than 70% of childhood and 50% of adult cancer patients can be cured, however this important success obtained by the biological and medical research is o...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
N Germann F Goffinet F Goldwasser

BACKGROUND Anthracyclines are essential for the treatment of malignancies observed in pregnant patients. Knowledge of the potential side-effects of chemotherapy on the developing fetus is essential for patient counseling. PATIENTS AND METHODS We collected information concerning patients treated with anthracyclines during pregnancy from a review of literature between 1976 and 2001 and our expe...

2017
Songjie Shen Ying Xu Yidong Zhou Feng Mao Jinghong Guan Qiang Sun

Background The regimen of concurrent administration of trastuzumab and anthracyclines in the adjuvant treatment of breast cancer has never been evaluated prospectively for fear of cardiac toxicity. Methods Patients with HER2-positive operable breast cancer were randomised to receive adjuvant treatment with concurrent or sequential administration of trastuzumab and anthracyclines. Cardiac moni...

2013
Woo Jung Jang Duk Yong Choi In-Sang Jeon

PURPOSE Anthracyclines have been utilized in the treatment of children with acute lymphoblastic leukemia (ALL). Recent studies have shown that anthracyclines may induce toxicity in the vascular endothelium. This study was performed using brachial artery reactivity (BAR) to evaluate vascular endothelial function in ALL patients who were treated with anthracycline chemotherapy. METHODS We inclu...

2013
Stefano Toldo Rachel W. Goehe Marzia Lotrionte Eleonora Mezzaroma Evan T. Sumner Giuseppe G. L. Biondi-Zoccai Ignacio M. Seropian Benjamin W. Van Tassell Francesco Loperfido Giovanni Palazzoni Norbert F. Voelkel Antonio Abbate David A. Gewirtz

PURPOSE The antineoplastic efficacy of anthracyclines is limited by their cardiac toxicity. In this study, we evaluated the toxicity of doxorubicin, non-pegylated liposomal-delivered doxorubicin, and epirubicin in HL-1 adult cardiomyocytes in culture as well as in the mouse in vivo. METHODS The cardiomyocytes were incubated with the three anthracyclines (1 µM) to assess reactive oxygen genera...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید